Investment Rating - The investment rating for the company is "Buy" (maintained) [1][6][22] Core Insights - The company has shown strong performance in the high-end domestic beauty market, with significant revenue growth and brand momentum [6][10] - The company reported a revenue of 2.59 billion RMB in H1 2025, representing a year-on-year increase of 31%, and a net profit of 670 million RMB, up 36% year-on-year [6][10] - The gross margin for H1 2025 was 84.2%, with a net profit margin of 25.9%, indicating effective cost control [6][10] Financial Data and Profit Forecast - Revenue projections for the company are as follows: - 2023: 2,886 million RMB - 2024: 3,885 million RMB - 2025E: 5,173 million RMB - 2026E: 6,852 million RMB - 2027E: 8,533 million RMB - Year-on-year growth rates for revenue are projected at 58% for 2023, 35% for 2024, and gradually decreasing to 25% by 2027 [5][13] - Net profit forecasts are as follows: - 2023: 662 million RMB - 2024: 881 million RMB - 2025E: 1,184 million RMB - 2026E: 1,542 million RMB - 2027E: 1,953 million RMB - The projected PE ratios are 64.7 for 2023, decreasing to 22.5 by 2027 [5][13] Segment Performance - The company experienced double-digit growth in both color cosmetics and skincare, with significant contributions from new product launches [6] - In H1 2025, color cosmetics revenue reached 1.42 billion RMB (up 31.1% YoY), while skincare revenue was 1.09 billion RMB (up 33.4% YoY) [6] - The fragrance segment also showed promising growth, with revenue of 11.41 million RMB, while the makeup training segment saw a decline of 5.9% [6] Channel Performance - The company has effectively released its potential across all channels, with offline revenue of 1.22 billion RMB (up 26.6% YoY) and online revenue of 1.297 billion RMB (up 39% YoY) [6] - The number of members reached 19 million, with a repurchase rate of 26.8%, indicating strong customer loyalty [6] Research and Development - The company is focused on innovation and international expansion, with new product launches planned and a research center set to support growth [6] - The company aims to penetrate the European and Asia-Pacific markets with localized teams and high-end channels [6] Brand Positioning - The company is positioned as a leading domestic beauty brand, capitalizing on the high-end color cosmetics market with a strong emphasis on unique aesthetics and product innovation [6]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company achieved a robust performance in the first half of 2025, with revenue and net profit increasing by 31.3% and 36.1% year-on-year, respectively [4] - The introduction of new fragrance products has further strengthened the company's high-end beauty positioning [8] - The company has successfully improved its operational efficiency, leading to a significant decrease in expense ratios [6][9] - The online and offline channels have both shown strong growth, with online sales increasing by 39% and offline sales by 26.6% [5] Financial Performance - In the first half of 2025, the company reported revenue of 2.59 billion yuan and a net profit of 670 million yuan, with an earnings per share (EPS) of 1.37 yuan [4] - The gross profit margin slightly decreased to 84.2%, while the net profit margin improved to 25.9% [6] - The company’s operating cash flow reached 830 million yuan, reflecting a year-on-year increase of 34.2% [7] Product and Channel Analysis - The revenue breakdown for the first half of 2025 shows that color cosmetics, skincare, fragrance, and makeup artistry training contributed 55%, 42%, 0.4%, and 2.6% to total revenue, respectively [5] - The company has expanded its offline presence with 405 self-operated counters and 32 distributor counters, marking a net increase of 27 and 1, respectively [5] Future Outlook - The company expects continued high-quality growth, with revised net profit forecasts for 2025, 2026, and 2027 set at 1.21 billion, 1.58 billion, and 2.04 billion yuan, respectively [9] - The current stock price corresponds to a price-to-earnings (P/E) ratio of 36 for 2025, indicating a favorable valuation [9]

Summary of Mao Geping Cosmetics Co. (1318.HK) Conference Call Company Overview - **Company**: Mao Geping Cosmetics Co. (1318.HK) - **Period**: 1H25 (First Half of 2025) Key Financial Metrics - **Sales**: RMB 2,588 million, up 31% year-over-year (yoy) [1][3] - **Net Income (NI)**: RMB 670 million, up 36% yoy [1][3] - **Operating Profit (OP)**: RMB 873 million, up 45% yoy [1][3] - **Gross Margin**: 84.2%, down 0.7 percentage points (ppt) yoy [10][12] - **Net Margin**: 25.9%, up 0.9 ppt yoy [13] Sales Performance By Channel - **Online Sales**: RMB 1,297 million, up 39% yoy, but 6% below Goldman Sachs estimates (GSe) [9][4] - **Offline Sales**: RMB 1,224 million, up 27% yoy, exceeding GSe by 3% [7][4] By Category - **Color Cosmetics**: RMB 1,422 million, up 31% yoy, contributing 55% of total sales [4][1] - **Skincare**: RMB 1,087 million, up 33% yoy, contributing 42% of total sales [4][1] - **Fragrance**: RMB 11 million in sales [4][1] Operating Efficiency - **Selling and Distribution Expenses**: Increased by 24.8% yoy to RMB 1,169 million, but 9% lower than GSe [11][12] - **Selling Expenses Ratio**: Declined by 2.4 ppt yoy to 45.2%, significantly below GSe of 48.8% [11][12] Future Outlook and Strategies - **Discussion Points for Upcoming Briefing**: 1. Sustainability of 1H margin and details behind selling expenses ratio decline [2] 2. Full year 2025 outlook [2] 3. Strategies for Double 11 sales event [2] 4. Skincare category strategy and online channel expansion [2] 5. Updates on fragrance line performance and new product pipelines [2] Risks and Considerations - **Key Risks**: 1. Variability in beauty consumption penetration in China [18] 2. Online penetration rates [18] 3. Development of new star SKUs, especially in skincare [18] 4. ROI on expanding consumer base [18] 5. Key person risk [18] Valuation and Price Target - **12-Month Price Target**: HK$ 86, based on a 25x 2027E P/E [17] - **Current Price**: HK$ 96.45, indicating a downside potential of 10.8% [20] Conclusion Mao Geping Cosmetics Co. has shown strong growth in sales and net income for 1H25, driven by both online and offline channels. The company is focusing on operational efficiency and has plans for future growth, particularly in the skincare category and online expansion. However, it faces risks related to market penetration and product development. The current valuation suggests a potential downside, warranting careful consideration for investors.

公告称，收入增加主要由于产品销售由上年同期的19亿元增加32.7%至截至2025年6月30日止六个月的 25.21亿元。 毛戈平(01318)发布截至2025年6月30日止六个月的中期业绩，收入25.88亿元(人民币，下同)，同比增加 31.28%;股东应占溢利6.7亿元，同比增加36.11%;每股基本盈利1.37元。 ...

Core Insights - The company reported a revenue of RMB 2.5882 billion for the first half of 2025, representing a year-on-year growth of 31.3% [1] - The net profit for the same period was RMB 670.4 million, showing a year-on-year increase of 36.1% [1] Revenue Breakdown - The sales revenue from color cosmetics reached RMB 1.4223 billion, with a year-on-year growth of 31.1% [1] - The sales revenue from skincare products amounted to RMB 1.0872 billion, reflecting a year-on-year increase of 33.4% [1] Product Innovation and Market Expansion - The company launched two new high-end perfume series, "Guoyun Ningxiang" and "Wendao Dongfang," expanding its product offerings into the fragrance market [1] - The new series emphasizes the company's philosophy of Eastern aesthetics, utilizing high-quality raw materials and craftsmanship [1] Brand Presence and Customer Engagement - As of June 30, 2025, the company has established brand counters in over 120 cities across China, including 405 self-operated counters and 32 distributor counters [2] - The company employs over 3,100 beauty consultants at its counters, making it one of the largest service teams among domestic and international beauty brands in China [2]

公告称，收入增加主要由于产品销售由上年同期的19亿元增加32.7%至截至2025年6月30日止六个月的 25.21亿元。 智通财经APP讯，毛戈平(01318)发布截至2025年6月30日止六个月的中期业绩，收入25.88亿元(人民 币，下同)，同比增加31.28%;股东应占溢利6.7亿元，同比增加36.11%;每股基本盈利1.37元。 ...

MAO GEPING COSMETICS CO., LTD. 毛戈平化妝品股份有限公司 （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） 提名委員會職權範圍 毛 戈 平 化 妝 品 股 份 有 限 公 司（「本公司」）的 提 名 委 員 會（「委員會」）職 權 範 圍（「職權範圍」）載 列 如 下。 1. 目 的 1.1 委 員 會 旨 在 物 色、考 慮 和 向 本 公 司 董 事（「董 事」）會（「董事會」）推 薦 合 適 人 選 出 任 董 事、監 管 評 估 董 事 會 表 現 的 流 程、制 訂 提 名 指 引 及 向 董 事 會 提 供 推 薦 建 議，有 關 指 引 須 符 合 任 何 適 用 法 律、 法 規 及 上 市 準 則。 2. 組 成 3. 會 議 3.1 除 下 文 另 有 指 明 外，本 公 司 的 公 司 章 程（「章 程」）（經 不 時 修 訂）所 載有關規範董事會議及議事程序的條文應適用於委員會會議及 議 事 程 序。 – 1 – 2.1 委 員 會 由 董 事 會 不 時 委 任，至 少 由 三 名 成 員 組 成，多 數 成 員 須 為 獨 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 MAO GEPING COSMETICS CO., LTD. 毛戈平化妝品股份有限公司 （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） （股 份 代 號：1318） 截 至2025年6月30日止六個月之中期業績公告 毛 戈 平 化 妝 品 股 份 有 限 公 司（「本公司」）董 事 會（「董事會」）謹 此 公 佈 本 公 司 及 其 附 屬 公 司（「本集團」）截 至2025年6月30日 止 六 個 月 之 未 經 審 計 業 績。 本公告列載本公司2025年 中 期 報 告 全 文，並 符 合 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則 中 有 關 中 期 業 績 初 步 公 告 附 載 的 資 料 之 要 求。 本公司審計委員會已審閱本集團截至2025年6月30日止六個月之中期 ...

Summary of Conference Call Industry Overview - The 2024 cosmetics market is showing a trend towards female-oriented consumption, with the high-end cosmetics segment performing exceptionally well, indicating significant potential for market upgrades [2][4] - Within high-end cosmetics, the base makeup category accounts for over 50% of the market share, making it the largest category, with structural upgrades driving the high-end trend [2][5] Key Insights and Arguments - The high-end base makeup price segment is growing faster than the mass price segment, with average prices across all price ranges on platforms like Tmall increasing [2][5] - Over the past five years, the overall average price of base makeup has consistently risen, with high-end brands on Tmall and Douyin showing a significantly higher market share compared to other categories, indicating a strong demand growth [2][5] - The company has seen a steady increase in its overall market share, with a growth rate from 2019 to 2023 that is only surpassed by USL and NAS. In 2023, the company achieved a 2% market share in the cosmetics sector, ranking 15th overall and 8th among high-end brands [2][6] Company Performance and Strategies - The company's online market share is increasing at a rate that far exceeds other foreign high-end brands, attributed to strong performances in traditional categories such as foundation, cushion, concealer, and highlighter, with these products ranking in the top ten [2][6] - The company is actively expanding into new product lines, such as black cream and skin clothing, which are expected to become new growth points and further solidify its position in the high-end base makeup market [2][6] Product Development Advantages - The company boasts a strong product development capability, led by a team centered around "Teacher Wang" and an artistic committee that deeply understands domestic consumer needs, continuously improving product quality [3][7] - This technical insight and research capability enable the company to launch high-quality products tailored to the characteristics of Chinese consumers, supporting its core competitiveness [3][7] Future Growth Drivers - From an investment perspective, the main drivers for the company's future development are the trend towards high-end base makeup products and the company's multi-faceted product layout strategy [2][8] - These factors together form the company's core competitive advantage, allowing it to maintain market leadership and achieve stable growth [2][8]

Group 1 - The top three companies with the highest short positions as of August 15 are WuXi AppTec (02359), CATL (03750), and COSCO Shipping Holdings (01919), with short ratios of 14.92%, 14.41%, and 13.40% respectively [1][2] - The companies with the largest absolute increase in short positions are Heng Rui Medicine (01276), Yao Cai Securities (01428), and Modern Animal Husbandry (01117), with increases of 2.49%, 1.34%, and 1.31% respectively [1][2] - The companies with the largest absolute decrease in short positions are Ganfeng Lithium (01772), WuXi AppTec (02359), and Fourth Paradigm (06682), with decreases of -2.98%, -2.67%, and -2.28% respectively [1][2] Group 2 - The top ten companies with the highest short ratios include Ping An Insurance (02318) at 12.46%, Green Leaf Pharmaceutical (02186) at 12.36%, and Vanke Enterprises (02202) at 12.13% [2] - The companies with the most significant increases in short ratios include Heng Rui Medicine (01276) from 0.51% to 2.99%, Yao Cai Securities (01428) from 3.47% to 4.81%, and Modern Animal Husbandry (01117) from 4.74% to 6.05% [2] - The companies with the most significant decreases in short ratios include Ganfeng Lithium (01772) from 13.32% to 10.34%, WuXi AppTec (02359) from 17.59% to 14.92%, and Fourth Paradigm (06682) from 2.74% to 0.46% [2][3]